Timothy M. Mayleben

Insider Reports History

Entity
Individual
Location
3621 South State St, 695 Kms Pl, Ann Arbor, MI
Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy M. Mayleben:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MARINUS PHARMACEUTICALS, INC. Director Common Stock 10.6K $12K $1.13 Oct 10, 2024 By Trust
MARINUS PHARMACEUTICALS, INC. Director Common Stock 6.9K $7.8K $1.13 Oct 10, 2024 Direct
MARINUS PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 10.5K Jun 18, 2024 Direct
Landos Biopharma, Inc. Director Stock Option (right to buy) 0 May 23, 2024 Direct

Insider Reports Filed by Timothy M. Mayleben

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRNS MARINUS PHARMACEUTICALS, INC. Oct 10, 2024 3 $0 4 Oct 15, 2024 Director
MRNS MARINUS PHARMACEUTICALS, INC. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
LABP Landos Biopharma, Inc. May 23, 2024 2 $0 4 May 23, 2024 Director
MRNS MARINUS PHARMACEUTICALS, INC. Jan 18, 2024 2 $0 4 Jan 19, 2024 Director
LABP Landos Biopharma, Inc. May 23, 2023 1 $0 4 May 24, 2023 Director
MRNS MARINUS PHARMACEUTICALS, INC. Jan 26, 2023 2 $0 4 Jan 30, 2023 Director
LABP Landos Biopharma, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
MRNS MARINUS PHARMACEUTICALS INC Feb 4, 2022 2 $0 4 Feb 7, 2022 Director
LABP Landos Biopharma, Inc. Dec 17, 2021 1 $0 4 Dec 21, 2021 Interim CEO, Director
LABP Landos Biopharma, Inc. May 13, 2021 1 $0 4 May 17, 2021 Director
LABP Landos Biopharma, Inc. May 13, 2021 0 $0 3 May 17, 2021 Director